These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28693488)

  • 1. Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries.
    Kovacs SD; Mills BM; Stergachis A
    Malar J; 2017 Jul; 16(1):282. PubMed ID: 28693488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President's Malaria Initiative proposals.
    Stergachis A; Bartlein RJ; Dodoo A; Nwokike J; Kachur SP
    Malar J; 2010 May; 9():148. PubMed ID: 20509971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening.
    Bowser D; Sparkes SP; Mitchell A; Bossert TJ; Bärnighausen T; Gedik G; Atun R
    Health Policy Plan; 2014 Dec; 29(8):986-97. PubMed ID: 24197405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dedicated health systems strengthening of the Global Fund to Fight AIDS, Tuberculosis, and Malaria: an analysis of grants.
    Fan VY; Tsai FJ; Shroff ZC; Nakahara B; Vargha N; Weathers S
    Int Health; 2017 Jan; 9(1):50-57. PubMed ID: 27986840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating operational research in programmes funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria in four sub-Saharan African countries.
    Camacho S; Maher D; Kamau EM; Saric J; Segura L; Zachariah R; Wyss K
    Global Health; 2020 Jul; 16(1):67. PubMed ID: 32711553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.
    Kuemmerle A; Dodoo AN; Olsson S; Van Erps J; Burri C; Lalvani PS
    Malar J; 2011 Mar; 10():57. PubMed ID: 21388536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operational and implementation research within Global Fund to Fight AIDS, Tuberculosis and Malaria grants: a situation analysis in six countries.
    Kiefer S; Knoblauch AM; Steinmann P; Barth-Jaeggi T; Vahedi M; Maher D; Utzinger J; Wyss K
    Global Health; 2017 Mar; 13(1):22. PubMed ID: 28340619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation.
    Lu C; Michaud CM; Khan K; Murray CJ
    Lancet; 2006 Aug; 368(9534):483-8. PubMed ID: 16890835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality changes after grants from the Global Fund to Fight AIDS, tuberculosis and malaria: an econometric analysis from 1995 to 2010.
    Yan I; Korenromp E; Bendavid E
    BMC Public Health; 2015 Sep; 15():977. PubMed ID: 26416543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global fund financing to the 34 malaria-eliminating countries under the new funding model 2014-2017: an analysis of national allocations and regional grants.
    Zelman B; Melgar M; Larson E; Phillips A; Shretta R
    Malar J; 2016 Feb; 15():118. PubMed ID: 26911998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
    Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
    Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Malaria Prevention and Control in Africa Through the Peace Corps-US President's Malaria Initiative Partnership.
    Henderson SJ; Belemvire A; Nelson R; Linn A; Moriarty LF; Brofsky E; Diaw M; Gittelman D
    Glob Adv Health Med; 2020; 9():2164956120976107. PubMed ID: 35174005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.
    Schmidt-Traub G
    Health Policy Plan; 2018 Apr; 33(3):335-344. PubMed ID: 29309574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global Fund-supported programmes contribution to international targets and the Millennium Development Goals: an initial analysis.
    Komatsu R; Low-Beer D; Schwartländer B
    Bull World Health Organ; 2007 Oct; 85(10):805-11. PubMed ID: 18038063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries.
    Isah AO; Opadeyi AO; Tumwijukye H; Cobelens F; Smith D; Ndomondo-Sigonda M; Harmark L; Tanui P; Tiemersma E; Mmbaga BT; Mahlangu G; Ayinbuomwan SA; Soulaymani R; Pandit JM
    Ther Adv Drug Saf; 2023; 14():20420986231188836. PubMed ID: 37529763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global fund financing of tuberculosis services delivery in prisons.
    Lee D; Lal SS; Komatsu R; Zumla A; Atun R
    J Infect Dis; 2012 May; 205 Suppl 2():S274-83. PubMed ID: 22448026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries.
    Vujicic M; Weber SE; Nikolic IA; Atun R; Kumar R
    Health Policy Plan; 2012 Dec; 27(8):649-57. PubMed ID: 22333685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are countries using global fund support to implement HIV drug resistance surveillance? A review of funded HIV grants.
    Kelley KF; Caudwell E; Xueref S; Ha TH; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4():S250-3. PubMed ID: 22544183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study.
    Ozawa S; Evans DR; Higgins CR; Laing SK; Awor P
    Malar J; 2019 Jan; 18(1):5. PubMed ID: 30626380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.